Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

Albany Molecular Research, Inc.

Sector: Commercial Physical And Biological Research Region: NY, United States


Exchange/Ticker: Nasdaq: AMRI


Company Description

Albany Molecular Research, Inc. provides scientific services, technologies and products. It provides contract services platform encompassing drug discovery, development and manufacturing services. The company operates through two segments: large scale manufacturing & discovery and Drug development & small scale manufacturing .The Large Scale Manufacturing & Discovery Segment includes pilot to commercial scale manufacturing of active pharmaceutical ingredients and intermediates, sterile syringe and vial filling and high potency and controlled substance manufacturing. The Drug Development & Small Scale Manufacturing Segment includes activities such as drug lead discovery, optimization, drug development and small scale commercial manufacturing. It operates in United States, Europe and Asia. The company was founded by Thomas E. D'Ambra on June 20, 1991 and is headquartered in Albany, NY.

Similar to: Medivir AB, Advanced Cell Technology, Inc., Exelixis, Inc.

Featured Company


Pool Corp.

Covington, LA, US

Pool Corp. markets and distributes swimming pool supplies and related products. It offers maintenance products, repair & replacement… Learn more →

You may also be interested in:


Exelixis, Inc.

South San Francisco, CA, US

Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical… Learn more →

Advanced Cell Technology,…

Marlborough, MA, US

Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases… Learn more →

Medivir AB

Stockholm, SE

Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products… Learn more →